Caracterización de la población con Fibromialgia en un Hospital de alta Complejidad, Bogotá D.C. Colombia 2018 – 2019

dc.contributorDaza Vergara, José Alejandro
dc.contributorIsaza Narváez, Ana Milena
dc.creatorArce Gutierrez, Juliana Elvira
dc.creatorGuevara Ruiz, Juan Camilo
dc.date.accessioned2020-08-04T16:25:49Z
dc.date.accessioned2022-09-22T14:17:15Z
dc.date.available2020-08-04T16:25:49Z
dc.date.available2022-09-22T14:17:15Z
dc.date.created2020-08-04T16:25:49Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/25836
dc.identifierhttps://doi.org/10.48713/10336_25836
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3437435
dc.description.abstractBackground: Fibromyalgia has a high prevalence in the general population, it varies according to the diagnostic criteria used due to its multidimensional etiology and complex pathophysiology. As a disorder of pain regulation, it is necessary to know the sociodemographic characteristics and comorbidities that affect this disease to build comprehensive interventions and preserve the functionality of patients. Methodology: Observational descriptive cross-sectional study, executing a search in 6689 medical records, corresponding to 1001 patients from the outpatient department of the pain and palliative care service in Méderi (2018 - 2019). 116 had a diagnosis of fibromyalgia and met the inclusion criteria. Results: Of the 116 patients diagnosed with fibromyalgia, 94% are women, 84.4% with 50 years or more, 67.2% had rheumatic comorbidity and 56% had psychiatric comorbidity, with consumption of 3 or more medications in 81% , use of opioid medications in 75%; 83.3% received non-pharmacological management. The diagnostic criteria for fibromyalgia were applied in 43.1% of the patients. It was evident that 10.3% had temporary disability and 7.8% had a disability pension. Conclusion: Fibromyalgia is a relevant pathology in the pain medicine clinic, requiring multiple interventions for its management and whose impact is difficult to measure and could represent a significant burden of morbidity for patients, in the performance of their job role and the economic impact to the health system.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Medicina del Dolor y Cuidado Paliativo
dc.publisherEscuela de Medicina y Ciencias de la Salud
dc.rightshttp://creativecommons.org/licenses/by-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.rightsAtribución-SinDerivadas 2.5 Colombia
dc.sourceFitzcharles MA, Perrot S, Häuser W. Comorbid fibromyalgia: A qualitative review of prevalence and importance. Vol. 22, European Journal of Pain (United Kingdom). Blackwell Publishing Ltd; 2018. p. 1565–76.
dc.source. Cardona-Arias JA, León-Mira V, Cardona-Tapias AA. Estado de salud y calidad de vida en pacientes con fibromialgia, Medellín. Revista Colombiana de Reumatologia. 2014;21(1):10–20.
dc.source. Clauw DJ. Fibromyalgia: A clinical review. Vol. 311, JAMA - Journal of the American Medical Association. American Medical Association; 2014. p. 1547–55.
dc.sourceHäuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano J v., Usui C, et al. Fibromyalgia. Nature Reviews Disease Primers. 2015 Aug 13;1.
dc.sourceCabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata JL. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Vol. 149, Medicina Clinica. Ediciones Doyma, S.L.; 2017. p. 441–8.
dc.source. Laroche F, Azoulay D, Trouvin AP, Coste J, Perrot S. Fibromyalgia in the workplace: Risk factors for sick leave are related to professional context rather than fibromyalgia characteristics- a French national survey of 955 patients. BMC Rheumatology. 2019;3(1).
dc.sourceBrill S, Ablin JN, Itay Goor-Aryeh Þ, Kim Hyat þ, Slefer A, Buskila D. Prevalence of Fibromyalgia Syndrome in Patients Referred to a Tertiary Pain Clinic [Internet]. 2012. Available from: http://jim.bmj.com/
dc.sourceSchmidt-Wilcke T, Diers M. New insights into the pathophysiology and treatment of fibromyalgia. Vol. 5, Biomedicines. MDPI AG; 2017.
dc.sourceHiggs JB. Fibromyalgia in Primary Care. Vol. 45, Primary Care - Clinics in Office Practice. W.B. Saunders; 2018. p. 325–41.
dc.sourceJones GT, Atzeni F, Beasley M, Flüß E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: A comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis and Rheumatology. 2015 Feb 1;67(2):568–75.
dc.sourcePérez de Heredia-Torres M, Huertas-Hoyas E, Máximo-Bocanegra N, Palacios-Ceña D, Fernández-De-Las-Peñas C. Cognitive performance in women with fibromyalgia: A case-control study. Australian occupational therapy journal. 2016 Oct 1;63(5):329–37.
dc.sourceArnold BS, Alpers GW, Süß H, Friedel E, Kosmützky G, Geier A, et al. Affective pain modulation in fibromyalgia, somatoform pain disorder, back pain, and healthy controls. European Journal of Pain. 2008 Apr;12(3):329–38.
dc.sourceArnold LM, Palmer RH, Gendreau RM, Chen W. Relationships Among Pain, Depressed Mood, and Global Status in Fibromyalgia Patients: Post Hoc Analyses of a Randomized, Placebo-Controlled Trial of Milnacipran. Psychosomatics. 2012 Jul;53(4):371–9.
dc.sourceArnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT Diagnostic Criteria for Fibromyalgia. Vol. 20, Journal of Pain. Churchill Livingstone Inc.; 2019. p. 611–28.
dc.sourceMacfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Flub E, et al. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases. 2017 Feb 1;76(2):318–28.
dc.sourceBerger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. International Journal of Clinical Practice. 2007 Sep;61(9):1498–508.
dc.sourceVincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. Prevalence of fibromyalgia: A population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care and Research. 2013 May;65(5):786–92.
dc.sourceGalek A, Erbslöh-Möller B, Köllner V, Kühn-Becker H, Langhorst J, Petermann F, et al. Psychische Störungen beim Fibromyalgiesyndrom: Screening in Einrichtungen verschiedener Fachrichtungen. Schmerz. 2013 Jun;27(3):296–304.
dc.sourceHäuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, et al. The German fibromyalgia consumer reports-a cross-sectional survey [Internet]. 2012. Available from: http://www.biomedcentral.com/1471-2474/13/74
dc.sourcePereira VB, Mesquita Ciconelli R, Bosi Ferraz Erika Rodrigues Senna M, Letícia De AP. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD [Internet]. Vol. 31, The Journal of Rheumatology Rheumatology The Journal. 2004.
dc.sourceFayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. Open [Internet]. 2016;6:10364. Available from: http://bmjopen.bmj.com/
dc.sourceGoldenberg DL. Diagnosing Fibromyalgia as a Disease, an Illness, a State, or a Trait? Vol. 71, Arthritis Care and Research. John Wiley and Sons Inc.; 2019. p. 334–6.
dc.sourceTreede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: The IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Vol. 160, Pain. Lippincott Williams and Wilkins; 2019. p. 19–27.
dc.sourceBuskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia: Genetic aspects of fibromyalgia syndrome. Vol. 8, Arthritis Research and Therapy. 2006.
dc.sourceArnold LM, Hudson JI, Hess E v., Ware AE, Fritz DA, Auchenbach MB, et al. Family Study of Fibromyalgia. Arthritis and Rheumatism. 2004 Mar;50(3):944–52.
dc.sourceLimer KL, Nicholl BI, Thomson W, Mcbeth J. Exploring the genetic susceptibility of chronic widespread pain: The tender points in genetic association studies. Vol. 47, Rheumatology. 2008. p. 572–7.
dc.sourceO’Brien AT, Deitos A, Triñanes Pego Y, Fregni F, Carrillo-de-la-Peña MT. Defective Endogenous Pain Modulation in Fibromyalgia: A Meta-Analysis of Temporal Summation and Conditioned Pain Modulation Paradigms. Vol. 19, Journal of Pain. Churchill Livingstone Inc.; 2018. p. 819–36.
dc.sourceJensen KB, Kosek E, Petzke F, Carville S, Fransson P, Marcus H, et al. Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain. 2009 Jul;144(1–2):95–100.
dc.sourceJulien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005;114(1–2):295–302.
dc.sourceLópez-Solà M, Woo CW, Pujol J, Deus J, Harrison BJ, Monfort J, et al. Towards a neurophysiological signature for fibromyalgia. Pain. 2017 Jan 1;158(1):34–47.
dc.sourceFallon N, Chiu Y, Nurmikko T, Stancak A. Functional connectivity with the default mode network is altered in fibromyalgia patients. PLoS ONE. 2016 Jul 1;11(7).
dc.sourceFang SC, Wu YL, Chen SC, Teng HW, Tsai PS. Subjective sleep quality as a mediator in the relationship between pain severity and sustained attention performance in patients with fibromyalgia. Journal of Sleep Research. 2019 Dec 1;28(6).
dc.sourceGendelman O, Amital H, Bar-On Y, Ben-Ami Shor D, Amital D, Tiosano S, et al. Time to diagnosis of fibromyalgia and factors associated with delayed diagnosis in primary care. Vol. 32, Best Practice and Research: Clinical Rheumatology. Bailliere Tindall Ltd; 2018. p. 489–99
dc.sourceRizzi M, Sacco OL, Radovanovic D, Sarzi-Puttini P. Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients. Clinical and experimental rheumatology [Internet]. 2017;35:74–80. Available from: https://www.researchgate.net/publication/320892040
dc.sourceMcLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis and Rheumatism. 2005 Nov;52(11):3660–9.
dc.sourceStaud R. Peripheral pain mechanisms in chronic widespread pain. Vol. 25, Best Practice and Research: Clinical Rheumatology. Bailliere Tindall Ltd; 2011. p. 155–64.
dc.sourceGrayston R, Czanner G, Elhadd K, Goebel A, Frank B, Üçeyler N, et al. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis. Seminars in Arthritis and Rheumatism. 2019 Apr 1;48(5):933–40.
dc.sourceGerdle B, Forsgren MF, Bengtsson A, Dahlqvist Leinhard O, Sören B, Karlsson A, et al. Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients - A 31P-MRS study. European Journal of Pain (United Kingdom). 2013 Sep;17(8):1205–15
dc.sourceGalvez-Sánchez CM, Reyes del Paso GA, Duschek S. Cognitive impairments in Fibromyalgia syndrome: Associations with positive and negative affect, alexithymia, pain catastrophizing and self-esteem. Frontiers in Psychology. 2018 Mar 22;9(MAR).
dc.sourceWalitt B, Čeko M, Khatiwada M, Gracely JL, Rayhan R, Vanmeter JW, et al. Characterizing “fibrofog”: Subjective appraisal, objective performance, and task-related brain activity during a working memory task. NeuroImage: Clinical. 2016;11:173–80.
dc.sourceElkana O, Falcofsky AK, Shorer R, Tamar Bar-On Kalfon M, Jacob Ablin MN. Does the cognitive index of the symptom severity scale evaluate cognition? Data from subjective and objective cognitive measures in fibromyalgia. Clin Exp Rheumatol [Internet]. 2019;37:51–7.
dc.sourceFuller-Thomson E, Nimigon-Young J, Brennenstuhl S. Individuals with fibromyalgia and depression: Findings from a nationally representative Canadian survey. Vol. 32, Rheumatology International. 2012. p. 853–62.
dc.sourceLøge-Hagen JS, Sæle A, Juhl C, Bech P, Stenager E, Mellentin AI. Prevalence of depressive disorder among patients with fibromyalgia: Systematic review and meta-analysis. Vol. 245, Journal of Affective Disorders. Elsevier B.V.; 2019. p. 1098–105.
dc.sourceGhiggia A, Romeo A, Tesio V, di Tella M, Colonna F, Geminiani GC, et al. Alexithymia and depression in patients with fibromyalgia: When the whole is greater than the sum of its parts. Psychiatry Research. 2017 Sep 1;255:195–7.
dc.sourceCarta MG, Moro MF, Pinna FL, Testa G, Cacace E, Ruggiero V, et al. The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life. International Journal of Social Psychiatry. 2018 Nov 1;64(7):647–55.
dc.sourcede Tommaso M, Federici A, Serpino C, Vecchio E, Franco G, Sardaro M, et al. Clinical features of headache patients with fibromyalgia comorbidity. Journal of Headache and Pain. 2011 Dec;12(6):629–38.
dc.sourceLodahl M, Treister R, Oaklander AL. Specific symptoms may discriminate between fibromyalgia patients with vs without objective test evidence of small-fiber polyneuropathy. Pain Reports. 2018 Jan 1;3(1).
dc.sourceCaro XJ, Galbraith RG, Winter EF. Evidence of peripheral large nerve involvement in fibromyalgia: a retrospective review of EMG and nerve conduction findings in 55 FM subjects. European Journal of Rheumatology [Internet]. 2018 Jun 1;5(2).
dc.sourceTing T v., Barnett K, Lynch-Jordan A, Whitacre C, Henrickson M, Kashikar-Zuck S. 2010 American College of Rheumatology Adult Fibromyalgia Criteria for Use in an Adolescent Female Population with Juvenile Fibromyalgia. Journal of Pediatrics.
dc.sourceWolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research. 2010 May;62(5):600–10.
dc.sourceViola-Saltzman M, Watson NF, Bogart A, Goldberg ; Jack, Buchwald D, Watson SM;, et al. High Prevalence of Restless Legs Syndrome among Patients with Fibromyalgia: A Controlled Cross-Sectional Study. Vol. 6, Journal of Clinical Sleep Medicine. 2010.
dc.sourceWolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia. Journal of Rheumatology. 2011 Jun;38(6):1113–22.
dc.sourceDean LE, Arnold L, Crofford L, Bennett R, Goldenberg D, Fitzcharles MA, et al. Impact of Moving From a Widespread to Multisite Pain Definition on Other Fibromyalgia Symptoms. Arthritis Care and Research. 2017 Dec 1;69(12):1878–86.
dc.sourceYang TY, Chen CS, Lin CL, Lin WM, Kuo CN, Kao CH. Risk for irritable bowel syndrome in fibromyalgia patients a national database study. Medicine (United States). 2015 Mar 1;94(10).
dc.sourceCastro-Marrero J, Faro M, Aliste L, Sáez-Francàs N, Calvo N, Martínez-Martínez A, et al. Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study. Psychosomatics. 2017 Sep 1;58(5):533–43.
dc.sourceCho SJ, Sohn JH, Bae JS, Chu MK. Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study. Headache. 2017 Nov 1;57(10):1583–92.
dc.sourceWhealy M, Nanda S, Vincent A, Mandrekar J, Cutrer FM. Fibromyalgia in migraine: A retrospective cohort study. Journal of Headache and Pain. 2018 Jul 31;19(1).
dc.sourceLai HH, Jemielita T, Sutcliffe S, Bradley CS, Naliboff B, Williams DA, et al. Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network Study. Journal of Urology. 2017 Sep 1;198(3):622–31.
dc.sourceJohnson CM, Makai GEH. Fibromyalgia and Irritable Bowel Syndrome in Female Pelvic Pain. Seminars in Reproductive Medicine. 2018;36(2):136–42.
dc.sourceAaron LA, Buchwald D. A Review of the Evidence for Overlap among Unexplained Clinical Conditions [Internet]. 2001. Available from: www.annals.org
dc.sourceHudson JI, Goldenberg DL. Comorbidity of Fibromyalgia With Medical and Psychiatric Disorders. The American Journal of Medicine. 1992;92:363–7.
dc.sourceSoriano-Maldonado A, Amris K, Ortega FB, Segura-Jiménez V, Estévez-López F, Álvarez-Gallardo IC, et al. Association of different levels of depressive symptoms with symptomatology, overall disease severity, and quality of life in women with fibromyalgia. Quality of Life Research. 2015 Dec 1;24(12):2951–7.
dc.sourceDiaz-Piedra C, Catena A, Sánchez AI, Miró E, Pilar Martínez M, Buela-Casal G. Sleep disturbances in fibromyalgia syndrome: The role of clinical and polysomnographic variables explaining poor sleep quality in patients. Sleep Medicine. 2015;16(8):917–25.
dc.sourceLiedberg GM, Björk M, Börsbo B. Self-reported nonrestorative sleep in fibromyalgia - Relationship to impairments of body functions, personal function factors, and quality of life. Journal of Pain Research. 2015 Aug 10;8:499–505.
dc.sourceAgarwal A, Oparin Y, Glick L, Fitzcharles MA, Adachi JD, Cooper MD, et al. Attitudes Toward and Management of Fibromyalgia: A National Survey of Canadian Rheumatologists and Critical Appraisal of Guidelines. Vol. 24, Journal of Clinical Rheumatology. Lippincott Williams and Wilkins; 2018. p. 243–9.
dc.sourceLuciano J v, Martı´nezmartı´nez N, Teresa Pen˜arrubia-Marıá M, Ferna´ndez-Vergel R, Garcıá-Campayo J, Camino Verduras J, et al. Effectiveness of a Psychoeducational Treatment Program Implemented in General Practice for Fibromyalgia Patients A Randomized Controlled Trial [Internet]. 2011. Available from: www.clinicalpain.com
dc.sourceHäuser W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M, et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: A systematic review and meta-analysis of randomised controlled trials. Arthritis Research and Therapy. 2010 May 10;12(3).
dc.sourceCarville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases. 2008 Apr;67(4):536–41
dc.sourcePerrot S, Russell IJ. More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta-analysis examining six core symptoms. Vol. 18, European Journal of Pain (United Kingdom). Blackwell Publishing Ltd; 2014. p. 1067–80.
dc.sourceArnold LM, Clauw DJ. Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. Vol. 129, Postgraduate Medicine. Taylor and Francis Inc.; 2017. p. 709–14.
dc.sourceBidonde J, Aj B, Sc W, Cl S, Danyliw A, Tj O, et al. Aquatic exercise training for fibromyalgia (Review) [Internet]. 2014. Available from: http://www.thecochranelibrary.com
dc.sourceTzellos TG, Toulis KA, Goulis DG, Papazisis G, Zampeli VA, Vakfari A, et al. Gabapentin and pregabalin in the treatment of fibromyalgia: A systematic review and a meta-analysis. Vol. 35, Journal of Clinical Pharmacy and Therapeutics. 2010. p. 639–56.
dc.sourceArnold LM, Keck PE, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Vol. 41, Psychosomatics. 2000. p. 104–13
dc.sourceTofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis Care & Research. 2004 Feb 15;51(1):9–13.
dc.sourceFitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, et al. Canadian pain society and canadian rheumatology association recommendations for rational care of persons with fibromyalgia. A summary report. Journal of Rheumatology. 2013 Aug;40(8):1388–93.
dc.sourceLera S, Gelman SM, López MJ, Abenoza M, Zorrilla JG, Castro-Fornieles J, et al. Multidisciplinary treatment of fibromyalgia: Does cognitive behavior therapy increase the response to treatment? Journal of Psychosomatic Research. 2009 Nov;67(5):433–41.
dc.sourceRooks DS, Gautam S, Romeling M, Martha B; Group Exercise, Education, and Combination Self-management in Women With Fibromyalgia A Randomized Trial [Internet]. Available from: http://archinte.jamanetwork.com/
dc.sourceWang C, Schmid CH, Fielding RA, Harvey WF, Reid KF, Price LL, et al. Effect of tai chi versus aerobic exercise for fibromyalgia: Comparative effectiveness randomized controlled trial. BMJ (Online). 2018;360.
dc.sourceDeclaration of Helsinki World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects [Internet]. 2018. Available from: www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
dc.sourceMinisterio de Salud R de C. RESOLUCION NUMERO 8430 DE 1993 (Octubre 4) [Internet]. RESOLUCION NUMERO 8430 DE 1993 (Octubre 4) 1993 p. 1–19. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.PDF
dc.sourceASEGURAMIENTO SANITARIO REGISTROS SANITARIOS Y TRAMITES ASOCIADOS GUIA PARA LA PRESENTACIÓN Y EVALUACIÓN DE MODIFICACIONES AL MANUAL DEL INVESTIGADOR [Internet]. 2019. Available from: https://www.invima.gov.co/documents/20143/1252100/ASS-RSA-GU037.pdf/840e2247-0077-93a1-f5a1-f24261ec690a?t=1561058438547
dc.sourceHäuser W, Perrot S, Sommer C, Shir Y, Fitzcharles MA. Diagnostic confounders of chronic widespread pain: Not always fibromyalgia. Vol. 2, Pain Reports. Lippincott Williams and Wilkins; 2017.
dc.sourceBidari A, Parsa BG, Ghalehbaghi B. Challenges in fibromyalgia diagnosis: From meaning of symptoms to fibromyalgia labeling. Vol. 31, Korean Journal of Pain. Korean Pain Society; 2018. p. 147–54.
dc.sourceWalitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey. Vol. 10, PLoS ONE. Public Library of Science; 2015.
dc.sourceWalitt B, Katz RS, Bergman MJ, Wolfe F. Three-quarters of persons in the US population reporting a clinical diagnosis of fibromyalgia do not satisfy fibromyalgia criteria: The 2012 National Health Interview Survey. PLoS ONE. 2016 Jun 1;11(6).
dc.sourceFitzcharles ChB M-AM, Ste-Marie BA PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary. Vol. 18, Pain Res Manag.
dc.sourceDailey DL, Keffala VJ, Sluka KA. Do cognitive and physical fatigue tasks enhance pain, cognitive fatigue, and physical fatigue in people with fibromyalgia? Arthritis Care and Research. 2015 Feb 1;67(2):288–96.
dc.sourceBusch AJ, Webber SC, Brachaniec M, Bidonde J, Bello-Haas VD, Danyliw AD, et al. Exercise therapy for fibromyalgia. Current Pain and Headache Reports. 2011 Oct;15(5):358–67.
dc.sourceArnold LM. Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Vol. 8, Arthritis Research and Therapy. 2006.
dc.sourcePeng X, Robinson RL, Mease P, Kroenke K, Williams DA, Chen Y, et al. Long-term evaluation of opioid treatment in fibromyalgia. Clinical Journal of Pain. 2015 Jan 14;31(1):7–13.
dc.sourceSommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, et al. Medikamentöse therapie des fibromyalgiesyndroms: Systematische übersicht und metaanalyse. Vol. 26, Schmerz. 2012. p. 297–310.
dc.sourceMcNett M, Goldenberg D, Schaefer C, Hufstader M, Baik R, Chandran A, et al. Treatment patterns among physician specialties in the management of fibromyalgia: Results of a cross-sectional study in the United States. Current Medical Research and Opinion. 2011 Mar;27(3):673–83
dc.sourceLiu Y, Qian C, Yang M. Treatment Patterns Associated with ACR-Recommended Medications in the Management of Fibromyalgia in the United States [Internet]. Vol. 22, JMCP Journal of Managed Care & Specialty Pharmacy. 2016. Available from: www.amcp.org
dc.sourceRobinson RL, Kroenke K, Mease P, Williams DA, Chen Y, Wohlreich M, et al. Burden of Illness and Treatment Patterns for Patients with Fibromyalgiap me_1475 1..11. 2008.
dc.sourceHäuser W, Perrot S, Clauw DJ, Fitzcharles MA. Unravelling Fibromyalgia—Steps Toward Individualized Management. Journal of Pain. 2018 Feb 1;19(2):125–34.
dc.sourceBennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders. 2007;8.
dc.sourceWalitt B, Fitzcharles MA, Hassett AL, Katz RS, Haüser W, Wolfe F. The longitudinal outcome of fibromyalgia: A study of 1555 patients. Journal of Rheumatology. 2011 Oct;38(10):2238–46.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectFibromialgia
dc.subjectDolor crónico generalizado
dc.subjectComorbilidad
dc.titleCaracterización de la población con Fibromialgia en un Hospital de alta Complejidad, Bogotá D.C. Colombia 2018 – 2019
dc.typemasterThesis


Este ítem pertenece a la siguiente institución